Amiytrophic Lateral Sclerosis (ALS). Motor neuron disease
Conditions
Interventions
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient with ALS diagnosis (according to Gold Coast criteria) Obtaining the score of 0, 1, or 2 in each ALS-FRS item Satisfaction for participation in the research project
Exclusion criteria
Exclusion criteria: Uncontrolled and severe adverse event
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient`s Function. Timepoint: baseline, after 3 months. Method of measurement: Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALS-FRS revised) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of lung function. Timepoint: Baseline and after 3 months. Method of measurement: Spirometry.;Interleukin-6. Timepoint: Baseline and after 3 months. Method of measurement: Blood test.;C-Reactive Protein (CRP). Timepoint: Baseline and after 3 months. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Emadzadeh
Mashhad University of Medical Sciences
Outcome results
None listed